Acorda Therapeutics, Inc. · Hawthorne, NY United States (NASDAQ: ACOR)
| 15 Skyline Dr. | Phone: 914-347-4300 |
| Hawthorne, NY | Fax: 914-347-4560 |
| 10532 | |
| United States | 
Map This Company |
Acorda Therapeutics, Inc. Rankings
More Companies in These Related Industries: Company Description
Acorda Therapeutics hopes its products really get on your nerves. The company is developing prescription drugs that aim to restore neurological function for patients with spinal cord injury and other central nervous system disorders. The company's marketed drugs include muscle spasm controller Zanaflex along with Ampyra, which enhances conduction in nerves damaged by blunt trauma or from multiple sclerosis (MS). It purchased the US rights to Zanaflex from
Acorda Therapeutics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ACOR Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 305 |
Executives
31 executives listed for Acorda Therapeutics, Inc.'s Hawthorne, NY location.
| President CEO, and Director | Ron Cohen | |
|---|---|---|
| CFO | David Lawrence | |
| Chief Scientific Officer | Andrew Blight |